Lung cancer screening decision aid adapted for patients at a safety-net health system
Official title: Adaptation and Pilot Testing of a Lung Cancer Screening Decision Aid for Patients From a Safety-Net Healthcare System
Run by M.D. Anderson Cancer Center · NCT07382557 · Data updated 2026-11-12
This project will test whether English and Spanish video and written decision aids help Harris Health patients who are current or recent smokers make clearer choices about lung cancer screening.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 50 Years to 80 Years |
| Sex | All |
| Enrollment | 360 (estimated) |
| Sponsor | M.D. Anderson Cancer Center Academic / other |
| Locations | 1 site (Houston, Texas) |
| Status | Recruiting |
| Started | September 29, 2022 |
| Main results expected | February 2, 2027 |
| Study ends | February 2, 2027 |
| Registry record updated | February 3, 2026 |
| Trial ID | NCT07382557 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal participants are English- or Spanish-speaking adults aged 50–80 who are current smokers or quit within the past 15 years, have no history of lung cancer, and are connected to the participating safety‑net healthcare system (and may include family members of someone with a history of smoking and lung cancer).
✕Probably not a fit
People outside the 50–80 age range, never-smokers, non-English/Spanish speakers, or those with a prior lung cancer diagnosis are unlikely to benefit from these adapted decision aids.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
The project first culturally and linguistically adapts an existing lung cancer screening video decision aid and written materials for low‑health‑literacy English and Spanish speakers served by a safety‑net system. Investigators will survey providers, run patient focus groups, and conduct cognitive interviews to refine the materials. In phase two, eligible patients will be randomized to view the adapted video decision aid or a control condition to measure acceptability and effects on decision-making outcomes. Outcomes include patient understanding, decision quality, and acceptability of the materials.
Why it matters
Potential benefit: If successful, patients could receive clearer, culturally relevant information that improves understanding and supports better decisions about lung cancer screening.
How similar studies have gone: Prior decision aids for lung cancer screening have improved patient knowledge and decision quality, but thorough cultural and low‑literacy adaptations for safety‑net populations have been less commonly tested.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. 50-80 years of age 2. Current smokers or smokers who have quit less than 15 years ago 3. Speak either English or Spanish 4. No history of lung cancer 5. Family member of someone with a history of smoking AND lung cancer Exclusion Criteria:
Where it's running
-
The University of Texas M. D. Anderson Cancer Center
Houston, Texas, United States Recruiting
Study contacts
- Principal investigator: Robert Vok, PHD — M.D. Anderson Cancer Center
- Study coordinator: Robert Volk, PHD
- Email: bvolk@mdanderson.org
- Phone: (713) 563-2509
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
ePRO in advanced lung cancer: emotional distress, brain metastasis, and symptom burden
This study tests how patients with advanced lung cancer—some with brain metastases—report emotional distress and symptoms over time using electronic questionnaires.
-
Urine VOC Test to Detect Lung Cancer in Never Smokers
A urine test that looks for volatile compounds is tested to see if it can help detect lung cancer in adults who have never smoked.
-
SI-B036 safety test in advanced and metastatic solid tumors
This early-phase study checks whether SI-B036 is safe and tolerable in adults with advanced or metastatic solid cancers who have had prior therapy.
-
Guaraná Supplement for Cancer-Related Fatigue in People Undergoing Treatment
This study tests whether taking guaraná capsules helps reduce cancer-related fatigue and improve quality of life in adults with breast, lung, colorectal, or gastric cancer who are actively receiving treatment.
-
ENPP1/cGAS and FAP in Solid Tumors in Vietnamese Patients
This Vietnam-based study will test ENPP1, cGAS, and FAP expression in archived tumor samples from Vietnamese adults with solid cancers using immunohistochemistry.
-
Olive oil before lung cancer surgery to see if it lowers chylothorax
This study tests whether drinking 40 mL of extra-virgin olive oil a few hours before lung cancer surgery can reduce chylothorax after tumor removal.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.